Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: amount (437), quantity (66), dose (869), measure (541), prescribed amount (134), measured quantity (28)

Ig request form 2 long term blue grey and unlisted requests v2 February 2014

Description: Immunoglobulin Request Form – All Long Term Blue and Grey use Please complete data below for the National Immunoglobulin Database –
Url: /Media/SUHTExtranet/TrustMedicinesFormulary/Forms/Ig-Request-Form-2-Long-term-Blue-Grey-unlisted-Requests-v2feb14.docx

Your medication after the birth of your baby - patient information

Description: A guide to your medication after the birth of your baby.
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Your-medication-after-the-birth-of-your-baby.pdf

Your steroid medication and emergency card - patient information

Description: This factsheet explains what adrenal insufficiency and adrenal crisis are, the symptoms to look out for and what to do if
Url: /Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Your-steroid-medication-and-emergency-card-3997-PIL.pdf

Tarlatamab (EAMS)

Description: Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) Tarlatamab (EAMS) Regimen • SCLC – Tarlatamab (EAMS) Indication • Tarlatamab is
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Tarlatamab-EAMS-Ver-1.0.pdf

Major trauma information pack

Description: MAJOR TRAUMA INFORMATION PACKFOREWORDDear ambulance clinician, Report after report over the last two decades have identified the ne
Url: /Media/SUHTExtranet/WessexTraumaNetwork/Majortraumainformationpack.pdf

ImatinibChronic

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (chronic phase) • CML – Imatinib (chronic phase) Indication • As the preferred first-lin
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibChronic.pdf

ImatinibAccelerated

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Regimen IMATINIB (accelerated phase) • CML - Imatinib (accelerated phase) Indication • As the preferred o
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/ImatinibAccelerated.pdf

SOP validation dose banding Aria ver1

Description: Central South Coast Cancer Network Standard Operating Procedure Validation of CSCCN Dose Banding in Aria (SOP:
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/SOPvalidationdosebandingAriaver1.pdf

VenetoclaxHigh

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia VENETOCLAX (high risk) Regimen • CLL – Venetoclax (high risk) Indication • Venetoclax is indicated for th
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VenetoclaxHigh.pdf

VR-RituximabVenetoclaxCycle_1_VenetoclaxDoseTitration

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia VR-RITUXIMAB-VENETOCLAX (high risk) Cycle 1 – Venetoclax dose titration Regimen • CLL – VR Rituximab Vene
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VR-RituximabVenetoclaxCycle-1-VenetoclaxDoseTitration.pdf

1 to 10 of 100

Previous 1 2 3 4 5 … Next